Price movement over the last 24 hours
ADMA Biologics Inc vs Reddit Inc — how do they compare? ADMA Biologics Inc trades at $9.18 (market cap $2.13B), while Reddit Inc trades at $194.06 (market cap $38.39B). The key difference: Reddit Inc is far larger — about 18× ADMA Biologics Inc's market cap, and Reddit Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | RDDT | |
|---|---|---|
Market Cap | $2.13B | $38.39B |
Sector | Health | Media |
52-Week High | $20.38 | $270.71 |
52-Week Low | $7.60 | $121.84 |
Enterprise Value | $2.20B | $35.64B |
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
Reddit (RDDT) trades at $200.67, up 3.13% today, reflecting strong momentum. The stock shows a bullish technical stance with moving averages aligned positively, though the RSI suggests potential overbought conditions. Fundamentally, the company exhibits robust revenue growth, with 2025 revenue at $2.2B and net income of $529.72M, supported by high gross margins of 91.37%. Recent earnings have mostly beaten expectations, and analyst sentiment is overwhelmingly positive with a consensus price target of $229.11. News highlights focus on AI safety initiatives and advertising growth.
The outlook for RDDT is favorable, driven by strong financial performance, expanding user engagement, and strategic AI investments. Key opportunities include sustained revenue growth and market share gains in social media. Risks involve competitive pressures, reliance on advertising revenue, and market volatility. With no sell ratings and solid cash flow generation, the stock presents a compelling case for growth-oriented investors, though valuation multiples remain elevated.
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →